Martee L. Hensley, MD of Memorial Sloan Kettering discusses trabectedin improves patients with drug resistant metastatic leiomyosarcoma at SGO 2016.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content